Add‐on felbamate vs placebo50% or greater reduction in seizure frequency · people with drug‐resistant focal epilepsy1 finding from 1 reviewFelbamate add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 83 participantsVery low